A Canadian licensed producer (LP) will begin raising capital in the public market after announcing an initial public offering (IPO).

Tilray, a private federally sanctioned cannabis producer in Canada since 2014, announced it will seek a Class 2 common stock listing on the NASDAQ Global Select Market with the ticker symbol “TLRY.”


Tilray has not determined how many shares will be offered in the IPO or the price range for the offering.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

“Cowen and BMO Capital Markets will jointly act as book runners for the proposed IPO,” Tilray revealed, with the two banking institutions splitting the duties of running the IPO between two countries. Cowen will lead the US launch and BMO the one in Canada.

The company indicated it has filed for a preliminary prospectus for a proposed IPO in Canada with the securities regulatory authorities of all Canadian provinces other than Quebec. However, Tilray doesn’t plan to list on any Canadian stock exchange.

One indicator as to why Tilray is electing to raise capital in the US rather than on a Canadian exchange relates to the limitations TMX Group has placed around possession and/or connection to US cannabis assets.

While Tilray sells medical cannabis to patients in Canada exclusively, Privateer Holdings, the parent company of the cannabis producer, also holds Marley Natural, a cannabis brand currently selling products in legal states California and Oregon. The brand offers cannabis oil cartridges, pre-rolls and whole flower for consumers.

The private producer will join fellow Canadian LP Cronos Group (NASDAQ:CRON,TSX:CRON) as one of the only cannabis companies on the NASDAQ. This year, Canopy Growth (NYSE:CGC,TSX:WEED) became the first cannabis company to list publicly on the New York Stock Exchange.

On Tuesday (June 19), Sandoz Canada, a drug maker, confirmed a partnership with Tilray to begin developing new product dosage forms and delivery systems. Tilray will begin offering eight of its existing cannabis products in partnership with Sandoz, meaning the pharmaceutical firm’s name and logo will be visible on the products.

The collaboration will also invest in research studies to “advance the science in a variety of medical conditions.”

“Both Sandoz and Tilray recognize that there continues to be an unmet need in access to, and dosing of, medical cannabis products,” said Michel Robidoux, president and general manager of Sandoz Canada.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less